Prostate Cancer Trial, Recruiting NCT05792722 Sponsor: Johns Hopkins University Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05792722
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with bladder cancer (confirmed by a lab test) and are scheduled to have your bladder surgically removed
  • Unusual or rare types of bladder cancer are also allowed
  • Having received treatment (such as chemotherapy) before surgery is allowed
  • You are over 18 years old
  • You are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

  • You are not considered a suitable candidate for bladder removal surgery
  • You have moderate to severe problems with erections, based on a score below 17 on a standard questionnaire (confirm with trial site)
  • Your bladder cancer has spread to the bladder neck or the prostate area, including the tube that runs through the prostate
  • You have previously had radiation treatment to your pelvic area
  • You have been diagnosed with prostate cancer
  • You have an abnormal prostate exam, a raised PSA blood test result (above 3), or a suspicious area seen on a prostate MRI scan — in these cases, a prostate biopsy would be needed to check for prostate cancer before joining
  • You have a family history that suggests a higher genetic risk of prostate cancer, for example: a close relative with breast cancer before age 50, ovarian cancer, pancreatic cancer, male breast cancer, certain bowel or womb cancers before age 50, or advanced prostate cancer at any age; or a father or brother diagnosed with prostate cancer before age 60; or two or more close relatives with breast or prostate cancer at any age; or three or more close relatives with cancers linked to Lynch syndrome (confirm with trial site)
  • You have been diagnosed with Lynch syndrome (an inherited condition that increases cancer risk)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Armine Smith, MD, Johns Hopkins University

Phone: 202-660-5561

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 October 2023
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Functional Outcomes as assessed by the Sexual Health Inventory for Men (SHIM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov